Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Sherwin

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|January 10, 2008
We speak for small biotechStephen A Sherwin
Nature Biotechnology|May 12, 2010
BIO's track record on emerging companiesRachel K King, Stephen A Sherwin
Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|January 10, 2008
We speak for small biotechStephen A Sherwin
Nature Biotechnology|May 12, 2010
BIO's track record on emerging companiesRachel K King, Stephen A Sherwin
Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.
Pageof 1